ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 48K)  | Related Articles | Citation Tracking

Case report
Continuous venovenous hemodiafiltration to treat controlled-release carbamazepine overdose in a pediatric patient
TULAY SAHIN YILDIZ MD*, DEMET GEDIKBASI TOPRAK MD, EMIN SAMI ARISOY MD, MINE SOLAK MD* AND KAMIL TOKER MD*
  *Department of Anaesthesiology, School of Medicine, University of Kocaeli, Kocaeli, Turkey and   Department of Pediatrics, School of Medicine, University of Kocaeli, Kocaeli, Turkey
Correspondence to Tulay Sahin Yildiz, PK: 17, Derince, 41900, Kocaeli, Turkey (email: tulaysahin00@yahoo.com; tsyildiz@yahoo.com).
Copyright 2006 The Authors Journal compilation 2006 Blackwell Publishing Ltd
KEYWORDS
anticonvulsants • carbamazepine • poisoning • overdose • haemodiafiltration

ABSTRACT

Carbamazepine (CBZ) intoxication is an important issue in acute poisoning practice. Highly protein-bound, CBZ is not removed efficiently through conventional hemodialysis. We describe the use of continuous venovenous hemodiafiltration (CVVHDF) in a 2-year-old boy who developed general tonic clonic seizure and respiratory depression due to controlled-release formula of CBZ overdose (peak drug level of >20 μg·ml−1, therapeutic range: 5–10 μg·ml−1). Serum CBZ concentrations fell to 0.25 μg·ml−1 at the end of hemodiafiltration. The patient recovered rapidly and was discharged from hospital 4 days from the time of ingestion with no complications or neurologic impairment.


Accepted 2 March 2006

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1460-9592.2006.01955.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Pediatric Anesthesia Pro-Con Debates
ESA 2010 - Register Now
Sign Up Now
Sign Up Now
Special Issue
Pediatric Anesthesia

Pediatric Anesthesia
Volume 19, Issue s1

Read The Pediatric Airway Special Issue here

Sign Up Now
Wiley Medical Twitter
Sign Up Now

Sign Up Now

Be the first to know about new research in your field

Sign up for FREE e-alerts from Wiley-Blackwell journals!

Sign Up Now